Isracann Biosciences Acquires Praesidio Health And Appoints Natural Health Products Officers
Isracann Biosciences Inc. (OTCPK:ISCNF) (CSE:IPOT) (XFRA:A2PT0E) has closed its acquisition of Praesidio Health Inc. Pursuant to the definitive agreement dated March 24, 2022 with Praesidio and the shareholders of Praesidio, the company acquired all of the issued and outstanding shares in the capital of Praesidio for aggregate c
